GSP Crop Science IPO is a Mainboard issue open from 16-18 March. The company is raising ₹400 Cr at a price band of ₹304 to ₹320 per share. One lot is 46 shares.
₹2
Implied listing gain: ₹332.30
1.64x
Times the issue was bid for
On the GMP figure: grey market premium is quoted by informal dealers. No exchange publishes it, no regulator oversees it, and it is not a forecast of the listing price. Issues quoting a strong premium have listed below their issue price. Weigh the financials and the risk factors in the RHP well above this number.
Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.
Minimum retail investment
₹14,720
46 shares at the upper band of ₹320
Retail limit
13 lots
the most that fits under the ₹2 lakh retail cap
Funds blocked after close
~6 days
from the closing date to listing
Total subscription
1.64x
across all categories
GMP-implied listing gain
+0.6%
₹2 premium on a ₹320 issue price
GSP Crop Science is a mainboard issue raising ₹400 Cr, offered in a band of ₹304–₹320 per share. At the upper end that is 32 times the ₹10 face value, so ₹310 of every share subscribed is share premium rather than capital.
A retail application for GSP Crop Science needs one lot of 46 shares, which works out to ₹14,720 at the upper band of ₹320. That is close to the ₹15,000 ceiling SEBI expects for a single retail lot, so an investor applying at cut-off is committing nearly the full retail limit per application. Retail applications are capped at ₹2,00,000, which here is 13 lots; bidding above that moves the application into the non-institutional category, and the large-HNI bucket begins at ₹10,00,000, or about 68 lots.
For GSP Crop Science, bidding runs 16-18 March, allotment is finalised on 20 March 2026, the shares list on 24 March 2026. Applications that do not receive an allotment have their UPI mandate released around 2 days after the issue closes. Counting from the close of bidding, money stays blocked for roughly 6 days before listing decides what the holding is worth.
The issue is reserved 50% to qualified institutional buyers, 15% to non-institutional investors, 35% to retail. A 35% retail share is the wider end of the range, which improves the odds for small applications when the book is only modestly oversubscribed. An oversubscribed retail portion is not allotted in proportion to the amount applied for: applications are reduced to single lots and drawn by lot, so several small applications from different PANs are more effective than one large one.
The book is 1.64x subscribed across all categories. That headline covers institutional, non-institutional and retail bids together, and allotment odds are decided within each category separately — an issue can be heavily subscribed overall while the retail portion is comfortable, or the other way round. An oversubscribed retail book is settled by a draw on single-lot applications, so more distinct PANs help where a bigger single bid does not.
MUFG Intime India Pvt. Ltd. is the registrar for this issue, which means the allotment status for GSP Crop Science is published on their portal from 20 March 2026. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.
A grey market premium of ₹2 on the upper band of ₹320 implies a listing gain of roughly 0.6%. The grey market is unofficial and unregulated, the premium can change daily, and it has no bearing on allotment — treat it as a sentiment reading, not a forecast.
This analysis is generated from the figures shown on this page and is for information only. It is not investment advice — read the RHP before you apply.
| IPO Date | 16-18 March |
| Face Value | ₹10 Per Share |
| Price Range | ₹304 to ₹320 |
| Issue Size | ₹400 Cr |
| Lot Size | 46 Shares |
| Allotment Date | 20 March 2026 |
| Listing Date | 24 March 2026 |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Category | Allocation |
|---|---|
| Retail Investors | 35% |
| QIB (Qualified Institutional Buyers) | 50% |
| HNI (High Net Worth Individuals) | 15% |
GSP Crop Science IPO is a Mainboard issue open from 16-18 March. The company is raising ₹400 Cr at a price band of ₹304 to ₹320 per share. One lot is 46 shares.
The issue is open 16-18 March. Bids must be placed, and any UPI mandate approved, before the cut-off on the closing day.
The price band is ₹304 to ₹320 per equity share, against a face value of ₹10. Retail investors may bid at cut-off, meaning they accept the final discovered price within this band.
The minimum application is 46 shares, and bids must be in multiples of that lot.
The total issue size is ₹400 Cr.
The issue is reserved as retail 35%, QIB 50%, HNI 15%. If the retail portion is oversubscribed, allotment there is decided by a lottery on lot-sized applications rather than in proportion to the amount applied for.
Basis of allotment is expected to be finalised on 20 March 2026. You can check your status on the registrar's website (MUFG Intime India Pvt. Ltd.) using your PAN.
Listing is expected on 24 March 2026, following the T+3 timeline that applies to Indian IPOs.
This information is for educational purposes only. Please conduct your own research and consult with financial advisors before making investment decisions. IPO investments carry market risks.
Or see the full upcoming IPO list, today's grey market premium, subscription figures and allotment status.

CMPDI IPO soon launch ho sakta hai jisme 7.14 crore shares OFS ke through offer kiye jayenge. Coal India shareholders ko special quota mil sakta hai. Yaha CMPDI IPO ki complete details aur investment strategy janiye.

US-Iran War ke baad se India mein crude oil $100 par, rupee record low ₹92 par, FPI ne ₹52,704 crore nikale, aur LPG sankat gahrata ja raha hai. Janiye is poori situation ka aapke investments par kya asar padega.

Global stock markets are reaching new record highs as technology companies lead the rally. Major indices like the S&P 500 and Nasdaq Composite have surged due to strong corporate earnings and growing investor confidence.